Major Clinical Response to Nivolumab in Relapsed/Refractory Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation
Bone Marrow Transplantation- United Kingdom
doi 10.1038/bmt.2015.346
Full Text
Abstract
Available in
Date
February 1, 2016
Authors
Publisher
Springer Science and Business Media LLC